Corpus ID: 19709880

' s response to reviews Title : Hit Identification of IKK-beta Natural Product Inhibitor

@inproceedings{MaSR,
  title={' s response to reviews Title : Hit Identification of IKK-beta Natural Product Inhibitor},
  author={V. Ma and Zhengqi Cheng and D. Chan and Ying-Wei Li}
}
We are pleased to note that the Reviewer 1 recognized our manuscript to be “well-written and well-structured and is an interesting field of research and it could contribute positively to the scientific community” and recommended this manuscript for publication with a few minor revisions. Reviewer 2 described our manuscript to be “clear and well-written” and suggested the publication with some revision. We have carefully analyzed the comments of the reviewer and editor and all issues raised… Expand
1 Citations
Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
TLDR
D6 may be a promising therapeutic agent for PC treatment and it provides a structural lead for the design of novel IKKβ inhibitors, as well as effectively inducing cancer cell apoptosis. Expand